Impact of baseline characteristics on glycemic effects of add-on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus. [electronic resource]
Producer: 20210706Description: 896-905 p. digitalISSN:- 2040-1124
- Acarbose -- administration & dosage
- Adamantane -- administration & dosage
- Aged
- Blood Glucose -- drug effects
- China
- Diabetes Mellitus, Type 2 -- blood
- Dipeptides -- administration & dosage
- Drug Therapy, Combination
- Female
- Glycated Hemoglobin -- drug effects
- Glycemic Control -- methods
- Humans
- Hypoglycemic Agents -- administration & dosage
- Male
- Metformin -- administration & dosage
- Middle Aged
- Postprandial Period
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.